Mutual Benefits Assurance Plc is a Nigerian insurance group listed on the Nigerian Exchange (NGX) since May 28, 2002, with principal activities spanning non-life insurance, life assurance and related financial services, supported by subsidiaries in Nigeria and selected West African markets.
Current price: N3.28
Rating: Buy
Price projection: N5 and N6.5
Technical Analysis
In this report, we shall use the following tools and analysis methods:
Elliott’s wave theory to understand the overall market sentiment
Fibonacci tools to determine support and resistance levels
The Relative Strength Index and volume to evaluate the market’s strength
The Money Flow Index to determine the market liquidity
Moving average and MACD to understand the nature of the trend
Top-down analysis to know the best investment position
Elliott wave analysis
Weekly chart: Market overview
Mutual Benefit experienced an irregular flat correction within Wave X of the grand cycle on the weekly chart. In line with this performance, the stock commenced its recovery phase. Liquidity and momentum remained flat as volume recovers. Notably, MACD’s divergence signal remained strong preparing investors for a trend reversal.
Daily chart: Investment opportunity
On the daily chart, MBENEFIT pulled back after a strong uptrend. Despite this bearish momentum, liquidity and momentum attempted to recover. Also, MACD sustained its divergence signal, aligning with the weekly chart’s MACD reading.
This performance suggests that the current position of the stock has strong potential for an uptrend. In line with this performance, investors should watch N2.50 and N3 as possible support levels
SWOT Analysis
Mutual Benefits Assurance Plc’s SWOT profile reflects an insurer with improving underwriting performance, stronger FY2025 earnings and an expanding equity base, supported by a broad product portfolio and a group structure with regional reach.
Its inclusion among insurers that met NAICOM’s recapitalisation requirements also provides an important foundation for continued operations under the new regulatory framework. However, declining operating cash flow, weaker total investment income and exposure to inflation, claims volatility and foreign-exchange movements remain material concerns.
The company’s ability to sustain its improved insurance service result, strengthen cash generation and allocate capital efficiently across its businesses will determine whether the current earnings recovery translates into lasting shareholder value. For investors, the outlook is cautiously constructive, but confirmation from subsequent financial results and share-price behaviour remains essential.
